MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 69 filers reported holding MIRUM PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $56,892,000 | -19.9% | 3,566,912 | 0.0% | 4.38% | -23.0% |
| Q3 2021 | $71,053,000 | +15.2% | 3,566,912 | 0.0% | 5.68% | -0.1% |
| Q2 2021 | $61,672,000 | -12.8% | 3,566,912 | 0.0% | 5.69% | +0.3% |
| Q1 2021 | $70,696,000 | +13.5% | 3,566,912 | 0.0% | 5.67% | +18.2% |
| Q4 2020 | $62,278,000 | -9.4% | 3,566,912 | 0.0% | 4.80% | -22.3% |
| Q3 2020 | $68,734,000 | -1.0% | 3,566,912 | 0.0% | 6.17% | +1.2% |
| Q2 2020 | $69,412,000 | +39.0% | 3,566,912 | 0.0% | 6.10% | +7.6% |
| Q1 2020 | $49,937,000 | -42.9% | 3,566,912 | 0.0% | 5.66% | -61.4% |
| Q4 2019 | $87,461,000 | +143.7% | 3,566,912 | 0.0% | 14.67% | +30.8% |
| Q3 2019 | $35,883,000 | – | 3,566,912 | – | 11.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
| NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
| BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
| Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
| BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
| Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
| Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
| Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
| Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |